279 related articles for article (PubMed ID: 25634359)
21. Rae1 drives NKG2D binding-dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells.
Zhao P; Yang L; Li X; Lu W; Lu F; Wang S; Wang Y; Hua L; Cui C; Dong B; Yu Y; Wang L
Cancer Sci; 2020 Jul; 111(7):2234-2247. PubMed ID: 32333709
[TBL] [Abstract][Full Text] [Related]
22. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.
Chen Y; Wei H; Sun R; Dong Z; Zhang J; Tian Z
Hepatology; 2007 Sep; 46(3):706-15. PubMed ID: 17626270
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cutaneous malignancy by gammadelta T cells.
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106
[TBL] [Abstract][Full Text] [Related]
24. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
Kim Y; Born C; Bléry M; Steinle A
Front Immunol; 2020; 11():960. PubMed ID: 32582150
[TBL] [Abstract][Full Text] [Related]
25. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
[TBL] [Abstract][Full Text] [Related]
26. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
[TBL] [Abstract][Full Text] [Related]
27. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
Front Immunol; 2018; 9():991. PubMed ID: 29867968
[TBL] [Abstract][Full Text] [Related]
28. Accumulation and activation of epidermal γδ T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype.
Sulcova J; Maddaluno L; Meyer M; Werner S
Eur J Immunol; 2015 Sep; 45(9):2517-28. PubMed ID: 26081170
[TBL] [Abstract][Full Text] [Related]
29. Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.
Konagai A; Yoshimura K; Hazama S; Yamamoto N; Aoki K; Ueno T; Fujioka M; Iijima H; Kato M; Uchida M; Wada T; Inoue M; Asao T; Fuse M; Wada S; Kuramasu A; Kamei R; Takeda S; Yamamoto S; Yoshino S; Oka M; Nagano H
Anticancer Res; 2017 Aug; 37(8):4093-4101. PubMed ID: 28739693
[TBL] [Abstract][Full Text] [Related]
30. In vivo activation of langerhans cells and dendritic epidermal T cells in the elicitation phase of murine contact hypersensitivity.
Tsuruta D; Kaneda K; Teramae H; Ishii M
Br J Dermatol; 1999 Mar; 140(3):392-9. PubMed ID: 10233256
[TBL] [Abstract][Full Text] [Related]
31. Ligands for murine NKG2D display heterogeneous binding behavior.
Carayannopoulos LN; Naidenko OV; Kinder J; Ho EL; Fremont DH; Yokoyama W
Eur J Immunol; 2002 Mar; 32(3):597-605. PubMed ID: 11857333
[TBL] [Abstract][Full Text] [Related]
32. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
Bui JD; Carayannopoulos LN; Lanier LL; Yokoyama WM; Schreiber RD
J Immunol; 2006 Jan; 176(2):905-13. PubMed ID: 16393975
[TBL] [Abstract][Full Text] [Related]
33. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
34. Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D).
Wang J; Nakafuku KM; Ziff J; Gelin CF; Gholami H; Thompson AA; Karpowich NK; Limon L; Coate HR; Damm-Ganamet KL; Shih AY; Grant JC; Côte M; Mak PA; Pascual HA; Rives ML; Edwards JP; Venable JD; Venkatesan H; Shi Z; Allen SJ; Sharma S; Kung PP; Shireman BT
Bioorg Med Chem Lett; 2023 Nov; 96():129492. PubMed ID: 37778428
[TBL] [Abstract][Full Text] [Related]
35. Regulatory NK1.1
Lin Z; Han S; Qian X; Hu C; Xiao W; Qian L; Zhang Y; Ding Y; Jia X; Zhu G; Gong W
Cancer Immunol Immunother; 2018 Jul; 67(7):1159-1173. PubMed ID: 29802426
[TBL] [Abstract][Full Text] [Related]
36. Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.
Nakamura K; Nakayama M; Kawano M; Amagai R; Ishii T; Harigae H; Ogasawara K
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9421-6. PubMed ID: 23690625
[TBL] [Abstract][Full Text] [Related]
37. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
Stojanovic A; Correia MP; Cerwenka A
Front Immunol; 2018; 9():827. PubMed ID: 29740438
[TBL] [Abstract][Full Text] [Related]
38. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
[TBL] [Abstract][Full Text] [Related]
39. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.
Champsaur M; Beilke JN; Ogasawara K; Koszinowski UH; Jonjic S; Lanier LL
J Immunol; 2010 Jul; 185(1):157-65. PubMed ID: 20530257
[TBL] [Abstract][Full Text] [Related]
40. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.
Carayannopoulos LN; Naidenko OV; Fremont DH; Yokoyama WM
J Immunol; 2002 Oct; 169(8):4079-83. PubMed ID: 12370332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]